Loading clinical trials...
Loading clinical trials...
To learn more about your experience participating in a virtual Meaning-Centered Psychotherapy group.
Primary Objectives The objectives are to describe the characteristics and outcomes of participants who attend at least one session of MCGP: 1. Describe demographic, clinical characteristics, reasons for referral, and IMC utilization data for participants who attend MCGP. 2. Examine anxiety, depression, quality of life, meaning in life, and fear of cancer recurrence before and after participation in MCGP. 3. Describe satisfaction and qualitative feedback from group participants, including perceived effectiveness and outcomes, experiences participating in the group virtually, and reactions to specific elements of the therapy modified for cancer survivors, length of group (90 minutes), and the nature of a closed group within the IMC. Secondary Objectives 4. Examine whether demographic, clinical, or symptoms-based (pre) measures are associated with number of MCGP sessions attended. 5. Examine whether number of sessions attended is associated with change in outcome measures.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
MD Anderson Cancer Center
Houston, Texas, United States
Start Date
October 3, 2025
Primary Completion Date
February 1, 2027
Completion Date
February 1, 2029
Last Updated
March 16, 2026
72
ESTIMATED participants
Therapy
OTHER
Lead Sponsor
M.D. Anderson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions